dehydroepiandrosterone has been researched along with Glioblastoma in 2 studies
Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Kim, SJ | 3 |
Park, SJ | 3 |
Park, J | 3 |
Cho, HJ | 3 |
Shim, JK | 3 |
Seon, J | 3 |
Choi, RJ | 3 |
Yoon, SJ | 3 |
Moon, JH | 3 |
Kim, EH | 3 |
Seo, EK | 3 |
Kim, SH | 3 |
Kim, HS | 3 |
Teo, WY | 3 |
Chang, JH | 3 |
Yook, JI | 3 |
Kang, SG | 3 |
Yang, WB | 1 |
Chuang, JY | 1 |
Ko, CY | 1 |
Chang, WC | 1 |
Hsu, TI | 1 |
2 other studies available for dehydroepiandrosterone and Glioblastoma
Article | Year |
---|---|
Dual inhibition of CPT1A and G6PD suppresses glioblastoma tumorspheres.
Topics: Animals; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Dehydroepiandrosterone; Glioblastoma; G | 2022 |
Dual inhibition of CPT1A and G6PD suppresses glioblastoma tumorspheres.
Topics: Animals; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Dehydroepiandrosterone; Glioblastoma; G | 2022 |
Dual inhibition of CPT1A and G6PD suppresses glioblastoma tumorspheres.
Topics: Animals; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Dehydroepiandrosterone; Glioblastoma; G | 2022 |
Dual inhibition of CPT1A and G6PD suppresses glioblastoma tumorspheres.
Topics: Animals; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Dehydroepiandrosterone; Glioblastoma; G | 2022 |
Dual inhibition of CPT1A and G6PD suppresses glioblastoma tumorspheres.
Topics: Animals; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Dehydroepiandrosterone; Glioblastoma; G | 2022 |
Dual inhibition of CPT1A and G6PD suppresses glioblastoma tumorspheres.
Topics: Animals; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Dehydroepiandrosterone; Glioblastoma; G | 2022 |
Dual inhibition of CPT1A and G6PD suppresses glioblastoma tumorspheres.
Topics: Animals; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Dehydroepiandrosterone; Glioblastoma; G | 2022 |
Dual inhibition of CPT1A and G6PD suppresses glioblastoma tumorspheres.
Topics: Animals; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Dehydroepiandrosterone; Glioblastoma; G | 2022 |
Dual inhibition of CPT1A and G6PD suppresses glioblastoma tumorspheres.
Topics: Animals; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Dehydroepiandrosterone; Glioblastoma; G | 2022 |
Dehydroepiandrosterone Induces Temozolomide Resistance Through Modulating Phosphorylation and Acetylation of Sp1 in Glioblastoma.
Topics: Acetylation; Brain Neoplasms; Cell Line, Tumor; Cell Nucleus; Dehydroepiandrosterone; DNA Damage; Dr | 2019 |